Clinical Trial: A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06979596) titled 'A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)' on May 13.

Brief Summary: Researchers want to learn if MK-5684 (the study medicine) can treat breast cancer, ovarian cancer, and endometrial cancer. MK-5684, the study medicine, is designed to treat cancer by blocking the body from making steroid hormones.

Researchers will compare MK-5684 to the standard treatments for each cancer type in this study.

The goal of this study is to learn if people who receive MK-5684 live longer without the cancer growing or spreading compared to people who receive a standard treatment.

Study Start Date: July 17

Study Ty...